Old Web
English
Sign In
Acemap
>
authorDetail
>
H.J. Siebelink
H.J. Siebelink
Leiden University Medical Center
Medicine
Evidence-based medicine
Intensive care medicine
Coronavirus disease 2019
Intensive care unit
5
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients.
2021
Netherlands Heart Journal
R. R. J. van Kimmenade
E. Belfroid
J Hoogervorst-Schilp
H.J. Siebelink
C. W. Janssen
Yigal M. Pinto
Show All
Source
Cite
Save
Citations (1)
Four guidelines on cardiovascular complications and cardiovascular disease, prognosis and treatment in COVID19.
2021
Netherlands Heart Journal
H.J. Siebelink
C.W. Jansen
E. Belfroid
J Hoogervorst-Schilp
Show All
Source
Cite
Save
Citations (0)
Effect of anticoagulant therapy in COVID-19 patients.
2021
Netherlands Heart Journal
Robert G. Tieleman
F. A. Klok
E. Belfroid
J Hoogervorst-Schilp
I. Schalkers
C.W. Jansen
H.J. Siebelink
Show All
Source
Cite
Save
Citations (1)
How often and to what extent do admitted COVID-19 patients have signs of cardiac injury?
2021
Netherlands Heart Journal
M A W Habets
H N Sturkenboom
R A Tio
E. Belfroid
J Hoogervorst-Schilp
H.J. Siebelink
C.W. Jansen
P.C. Smits
Show All
Source
Cite
Save
Citations (3)
Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients.
2021
Netherlands Heart Journal
Lucia S.D. Jewbali
J Hoogervorst-Schilp
E. Belfroid
C.W. Jansen
Folkert W. Asselbergs
H.J. Siebelink
Show All
Source
Cite
Save
Citations (2)
1